Steven Cohen's position in Intra-Cellular Therapies is currently worth $33.2 Million. That's 0.10% of their equity portfolio (253rd largest holding). The first Intra-Cellular Therapies trade was made in Q1 2015. Since then Steven Cohen bought shares fifteen more times and sold shares on fifteen occasions. The stake costed the investor $18.1 Million, netting the investor a gain of 84% so far.